Risk factors for diabetes insipidus in langerhans cell histiocytosis

Background Diabetes insipidus (DI) is the most frequent central nervous system (CNS)‐related permanent consequence in Langerhans cell histiocytosis (LCH), which mostly requires life‐long hormone replacement therapy. In an attempt to define the population at risk for DI, 1,741 patients with LCH regis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric Blood & Cancer 2006-02, Vol.46 (2), p.228-233
Hauptverfasser:	Grois, N., Pötschger, U., Prosch, H., Minkov, M., Arico, M., Braier, J., Henter, J-I., Janka-Schaub, G., Ladisch, S., Ritter, J., Steiner, M., Unger, E., Gadner, H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences central nervous system Clinical Trials as Topic diabetes insipidus Diabetes Insipidus, Neurogenic - complications Diabetes Insipidus, Neurogenic - drug therapy Diabetes Insipidus, Neurogenic - pathology Female Follow-Up Studies General aspects Histiocytosis, Langerhans-Cell - drug therapy Histiocytosis, Langerhans-Cell - etiology Histiocytosis, Langerhans-Cell - pathology Hormone Replacement Therapy Humans langerhans cell histiocytosis magnetic resonance imaging Male Medical sciences Retrospective Studies Risk Factors Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!